Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...

Bought by GSK under the leadership of Walmsley’s predecessor, Sir Andrew Witty, the business makes protein bars, drinks and powders and is best known for its Maximuscle products for weight training.

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...